Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with early breast cancer: preliminary results

E.Ricevuto; Grassadonia; E.Cianchetti; S.Grossi; D.Angelucci; G.Castrilli; A.I.Rispoli; C.Natoli; C.Ficorella; S.Iacobelli

首页> 外文期刊>European Journal of Cancer Supplements >Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with early breast cancer: preliminary results

【24h】

Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with early breast cancer: preliminary results

机译：早期乳腺癌患者术前使用表柔比星/环磷酰胺进行剂量密集的序贯化疗，然后进行多西他赛/卡培他滨治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第2期|共1页
作者
E.Ricevuto; Grassadonia; E.Cianchetti; S.Grossi; D.Angelucci; G.Castrilli; A.I.Rispoli; C.Natoli; C.Ficorella; S.Iacobelli;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer [J] . Minmin Zhang, Wei Wei, Jianlun Liu, OncoTargets and therapy . 2016,第1期

机译：在可手术乳腺癌患者中，新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
2. A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. [J] . Natoli C, Cianchetti E, Tinari N, Annals of oncology: official journal of the European Society for Medical Oncology . 2007,第6期

机译：一项II期研究，该研究采用剂量密集的表柔比星加环磷酰胺，然后多西他赛加卡培他滨和培格非司亭支持作为II，IIIA期乳腺癌患者的术前治疗。
3. A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer [J] . C Natoli1 E Cianchetti2 N Tinari1 D Angelucci1 A Grassadonia1 M Zilli1 C Ficorella3 E Ricevuto3 S Grossi2 M De Tursi1 C Carella1 AI Rispoli3 and S Iacobelli1 Annals of Oncology . 2007,第6期

机译：II期IIIA期乳腺癌患者的剂量密集表柔比星联合环磷酰胺再加多西他赛联合卡培他滨和培非非司亭支持的II期研究
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy [O] . 2013

机译：5-氟尿嘧啶-厄比霉素-环磷酰胺（FEC）4周期早期乳腺癌患者术前多西他赛联合或不联合卡培他滨的随机试验：探索性分析确定Ki67为新辅助化疗反应的预测生物标志物

Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with early breast cancer: preliminary results

著录项

相似文献

相关主题

期刊订阅